Seasonal Flu Diagnostic Elisa Kit 2017

Human Influenza viruses IgG(FLU-IgG) ELISA Kit

SL0927Hu 96 Tests
EUR 468

Human IgG antibody Laboratories manufactures the seasonal flu diagnostic elisa kit 2017 reagents distributed by Genprice. The Seasonal Flu Diagnostic Elisa Kit 2017 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza elisa. Other Seasonal products are available in stock. Specificity: Seasonal Category: Flu Group: Diagnostic Elisa

Human FLU ELISA Kit

96Tests
EUR 625.2

Human FLU-H5 ELISA Kit

96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human FLU-H5 ELISA Kit

96T
EUR 433.2

Human FLU-H5 ELISA Kit

48T Ask for price

Human FLU-H5 ELISA Kit

96T Ask for price

Human True insulin ELISA kit

192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit

1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Diagnostic Elisa information

Diagnostic Bottle - HDPE Round Bottle with PP Closure - PK2000

312002-9025 PK2000
EUR 2134.35

Tip 300uL Conductive - Type Qiagen And Diagnostic N/ST - PK2304

PIP1690 PK2304
EUR 469.8

Seasonal H1N1 Hemagglutinin Peptide

5231P 0.05 mg
EUR 197.7
Description: Seasonal H1N1 Hemagglutinin peptide

Seasonal H1N1 Hemagglutinin Peptide

5235P 0.05 mg
EUR 197.7
Description: Seasonal H1N1 Hemagglutinin peptide

Seasonal H1N1 Hemagglutinin Peptide

5239P 0.05 mg
EUR 197.7
Description: Seasonal H1N1 Hemagglutinin peptide

Seasonal H1N1 Neuraminidase Peptide

5247P 0.05 mg
EUR 197.7
Description: Seasonal H1N1 Neuraminidase peptide

Seasonal H1N1 Hemagglutinin Antibody

24917 100ul
EUR 479

Seasonal H1N1 Hemagglutinin Antibody

24917-100ul 100ul
EUR 468

Seasonal H1N1 Hemagglutinin Antibody

24919 100ul
EUR 479

Seasonal H1N1 Hemagglutinin Antibody

24919-100ul 100ul
EUR 468

Seasonal H1N1 Hemagglutinin Antibody

24921 100ul
EUR 479

Seasonal H1N1 Hemagglutinin Antibody

24921-100ul 100ul
EUR 468

Seasonal H1N1 Neuraminidase Antibody

24924 100ul
EUR 479

Seasonal H1N1 Neuraminidase Antibody

24924-100ul 100ul
EUR 468

Seasonal H1N1 Hemagglutinin Antibody

5231-002mg 0.02 mg
EUR 206.18
Description: Seasonal H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Seasonal H1N1 Hemagglutinin Antibody

5231-01mg 0.1 mg
EUR 523.7
Description: Seasonal H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Seasonal H1N1 Hemagglutinin Antibody

5235-002mg 0.02 mg
EUR 206.18
Description: Seasonal H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.